NanoViricides Inc. (NNVC)

[Doctor_Hari_Seldon]

Cases in Florida, Texas and New York, in addition to 25,000 suspected cases reported in Puerto Rico this past summer, the Dengue virus is clearly becoming an important pathogen of concern in the United States.

NanoViricide's DengueCide™ drug candidate has been awarded orphan drug status by the U.S. Food and Drug Administration (FDA) as well as the European Medicines Agency (EMA), covering the USA and all the 27 countries within the European Union. This drug candidate has shown unprecedented effectiveness in a special mouse model that simulates secondary dengue/dengue hemorrhagic fever.